Erratum: Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial [Corrigendum]

Clin Ophthalmol. 2018 May 17:12:913. doi: 10.2147/OPTH.S168970. eCollection 2018.

Abstract

[This corrects the article on p. 263 in vol. 12, PMID: 29440868.].

Publication types

  • Published Erratum